Published financial brief
3RPBIF
RESPONSE BIOMEDICAL CORP
- As of
- 2015-12-31
- Source
- Supabase fundamentals
- Calculator
- financial-roic-1.0.0
- Published
- 7/26/2026
2 data notes
- Input provenance requires review.
- One or more values are unavailable.
Exact-period record
Fundamentals
5 reported periods
| Metric | FY 20112011-12-31 | FY 20122012-12-31 | FY 20132013-12-31 | FY 20142014-12-31 | FY 20152015-12-31 |
|---|---|---|---|---|---|
| Financial statements | |||||
| RevenueUSD millions | 9.5 | 11.8 | 11.5 | 11 | 15.4 |
| Cost of goods soldUSD millions | 6.2 | 6.8 | 6 | 6 | 6.7 |
| Selling, general and administrative expenseUSD millions | 6.7 | 8 | 7.8 | 9 | 7.4 |
| Depreciation and amortizationUSD millions | 1.3 | 1.1 | 1 | 1 | 1 |
| Net incomeUSD millions | -5.4 | -5.3 | -6 | -2.1 | -0.2 |
| Operating profit (EBIT)USD millions | -4.8 | -4.2 | -3.2 | -5 | 0.3 |
| Income taxesUSD millions | 0 | 0 | 0 | 0.1 | 0 |
| Short-term debtUSD millions | 0 | 0 | 0 | 0.5 | 0.8 |
| Long-term debtUSD millions | 0 | 0 | 0 | 1 | 0.4 |
| Cash and equivalentsUSD millions | 7.4 | 2.1 | 3 | 3.2 | 2.5 |
| ReceivablesUSD millions | 1.7 | 1.7 | 1 | 0.8 | 0.6 |
| InventoryUSD millions | 2.2 | 1.8 | 2.3 | 2.1 | 1.8 |
| PayablesUSD millions | 1.3 | 0.5 | 1.2 | 1.6 | 1 |
| Net property, plant and equipmentUSD millions | 8.4 | 7.6 | 6.8 | 6.3 | 5.7 |
| Capital expenditureUSD millions | 0.1 | 0.3 | 0.2 | 0.4 | 0.4 |
| Operating cash flowUSD millions | -2.6 | -4.6 | -1.3 | -2.3 | 0.8 |
| Prepaid expensesUSD millions | —missing | —missing | —missing | —missing | —missing |
| AccrualsUSD millions | 2.2 | 1.4 | 1.5 | 2.2 | 2.3 |
| EBITDAUSD millions | -3.4 | -3.1 | -2.2 | -4 | 1.3 |
| Working capitalUSD millions | 3.8 | -0.6 | -2.2 | -0.8 | -1.3 |
| Working capital requirementUSD millions | 2.5 | 2.9 | 2 | 1.2 | 1.4 |
| Total debtUSD millions | 0 | 0 | 0 | 1.5 | 1.2 |
| Free cash flowUSD millions | -2.7 | -4.9 | -1.5 | -2.7 | 0.4 |
| Unlevered free cash flowUSD millions | -1.9 | -3.8 | -1.5 | -3.7 | 0.6 |
| Returns and ratios | |||||
| ROICratio | -43.5% | -39.9% | -36.3% | -67.3% | 4% |
| Pre-tax ROICratio | -43.5% | -39.9% | -36.3% | -67.3% | 4% |
| Effective tax rateratio | 0% | 0% | 0% | 0% | 0% |
| Revenue growthratio | 24.5% | 24% | -1.9% | -4.5% | 40% |
| EBIT / Revenueratio | -50.3% | -35.8% | -27.8% | -45.7% | 1.8% |
| Revenue / Invested capitalmultiple | 0.86× | 1.11× | 1.31× | 1.47× | 2.17× |
| Cogs Over Revenuesratio | 65.1% | 58.1% | 51.8% | 54.6% | 43.6% |
| Sga Over Revenuesratio | 71.1% | 67.9% | 67.4% | 82% | 48.1% |
| Da Over Revenuesratio | 14.1% | 9.7% | 8.6% | 9% | 6.5% |
| Nfa Over Revenuesratio | 89% | 64.7% | 59.1% | 56.7% | 36.9% |
| Wcr Over Revenuesratio | 26.6% | 25% | 17.4% | 11.1% | 9.2% |
| Debt Over Ebitdamultiple | —missing | —missing | —missing | —missing | 0.93× |
| St Debt Over Cashmultiple | 0× | 0× | 0× | 0.15× | 0.34× |
| Interest Over Ebitdamultiple | —missing | —missing | —missing | —missing | 0.68× |
| Interest Over Nocf Nicfmultiple | -0.32× | -0.15× | -0.47× | -0.32× | 2.41× |
| Nsf Over Wcrmultiple | -2.92× | -0.71× | -1.48× | -2.23× | -1.18× |
Ask this snapshot
Research assistant
3RPBIF · annualSnapshot 81a75a98
Answers use only this published snapshot. The assistant will say when the data is insufficient and does not create forecasts, scenarios, or investment advice.
0 / 2,000